Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
Franceschi E, Depenni R, Paccapelo A, Ermani M, Faedi M, Sturiale C, Michiara M, Servadei F, Pavesi G, Urbini B, Pisanello A, Crisi G, Cavallo MA, Dazzi C, Biasini C, Bertolini F, Mucciarini C, Pasini G, Baruzzi A, Brandes AA; PERNO Study Group. Franceschi E, et al. Among authors: depenni r. J Neurooncol. 2018 Jan;136(1):221-222. doi: 10.1007/s11060-017-2638-y. J Neurooncol. 2018. PMID: 29124650
First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.
Le Tourneau C, Ghiani M, Cau MC, Depenni R, Ronzino G, Bonomo P, Montesarchio V, Leo L, Schulten J, Salmio S, Messinger D, Sbrana A, Borcoman E, Ghi MG. Le Tourneau C, et al. Among authors: depenni r. Cancer Rep (Hoboken). 2023 May;6(5):e1804. doi: 10.1002/cnr2.1804. Epub 2023 Apr 17. Cancer Rep (Hoboken). 2023. PMID: 37069784 Free PMC article.
Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF. Bertolini F, et al. Among authors: depenni r. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1455-61. doi: 10.1016/j.ijrobp.2007.02.018. Epub 2007 Apr 18. Int J Radiat Oncol Biol Phys. 2007. PMID: 17445998
Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.
Bertolini F, Chiara S, Bengala C, Antognoni P, Dealis C, Zironi S, Malavasi N, Scolaro T, Depenni R, Jovic G, Sonaglio C, Rossi A, Luppi G, Conte PF. Bertolini F, et al. Among authors: depenni r. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):466-72. doi: 10.1016/j.ijrobp.2008.04.065. Epub 2008 Nov 10. Int J Radiat Oncol Biol Phys. 2009. PMID: 19004567 Clinical Trial.
Survival in patients with newly diagnosed conventional glioblastoma: a modified prognostic score based on a single-institution series.
Bertolini F, Zunarelli E, Baraldi C, Valentini A, Del Giovane C, Depenni R, Falasca A, Giacobazzi P, Malagoli M, Meletti S, Fontana A, Conte P; Gruppo Neuro Oncologico Modena (GNO-MO). Bertolini F, et al. Among authors: depenni r. Tumori. 2012 Nov;98(6):756-61. doi: 10.1177/030089161209800613. Tumori. 2012. PMID: 23389363
Brain metastases: an overview.
Bertolini F, Spallanzani A, Fontana A, Depenni R, Luppi G. Bertolini F, et al. Among authors: depenni r. CNS Oncol. 2015;4(1):37-46. doi: 10.2217/cns.14.51. CNS Oncol. 2015. PMID: 25586424 Free PMC article. Review.
65 results